Idiopathic CD4+ T lymphocytopenia disclosed after the diagnosis of visceral leishmaniasis [4]

Clinical Infectious Diseases

Volumn 44, Issue 11, 2007, Pages 1522-1523

  Lopez Medrano F ^a   Aguado, J M ^a   Ruiz Contreras, J ^a   Alvarez N ^a   Delgado, J M ^a   San Juan, R ^a   Lizasoain, M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CD4 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; STEROID;

ADULT; ASTHENIA; CASE REPORT; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE TRANSMISSION; ECZEMA; FEVER; HUMAN; HUMAN CELL; LEISHMANIA; LETTER; LYMPHADENOPATHY; LYMPHOCYTOPENIA; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SYMPTOM; VISCERAL LEISHMANIASIS; WEIGHT REDUCTION;

ADULT; ANIMALS; CD4 LYMPHOCYTE COUNT; HUMANS; LEISHMANIA; LEISHMANIASIS, VISCERAL; MALE; T-LYMPHOCYTOPENIA, IDIOPATHIC CD4-POSITIVE;

EID: 34249021117     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/519139     Document Type: Letter

References (6)

1. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet 2005; 366:1561-77.
2. von Stebut E, Udey MC. Requirements for Th1-dependent immunity against infection with Leishmania major. Microbes Infect 2004; 6:1102-9.
3. Lopez-Velez R. The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are coinfected with HIV. Ann Trop Med Parasitol 2003; 97(Suppl 1):143-7.
4. + T-lymphocyte depletion in persons without evident HIV infection - United States. MMWR Morb Mortal Wkly Rep 1992; 41:541-5.
5. + T-lymphocytopenia Task Force. N Engl J Med 1993; 328:373-9.
6. Walker UA, Warnatz K. Idiopathic CD4 lymphocytopenia. Curr Opin Rheumatol 2006; 18:389-95.